...So welcome again. Good morning or good afternoon, wherever you're coming from. It's Pete here from the Citi Pharma team. I'm delighted to be introducing Frank Nestle, who is the CSO at Sanofi and Head of Research. We also have with us the IR team. For those who have been on the conference, it's now day 3, 3 or 4. I'm sure you're hearing me say this, but I will, as always, I'm here to moderate, not monopolize. (Operator Instructions) I will make sure there's questions that I'll put it to Frank. This is going to be pure Q&A rather than prepared slides or commentary because there's a lot to go through. So maybe Frank, I'm kicking off -- sorry to interrupt you there....